A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Down syndrome (DS) is caused by the presence of an extra copy of human chromosome 21 (Hsa21) and is the most common genetic cause for developmental cognitive disability. The regions on Hsa21 are syntenically conserved with three regions located on mouse chromosome 10 (Mmu10), Mmu16 and Mmu17. In this report, we describe a new mouse model for DS that carries duplications spanning the entire Hsa21 syntenic regions on all three mouse chromosomes. This mouse mutant exhibits DS-related neurological defects, including impaired cognitive behaviors, reduced hippocampal long-term potentiation and hydrocephalus. These results suggest that when all the mouse orthologs of the Hsa21 genes are triplicated, an abnormal cognitively relevant phenotype is the final outcome of the elevated expressions of these orthologs as well as all the possible functional interactions among themselves and/or with other mouse genes. Because of its desirable genotype and phenotype, this mutant may have the potential to serve as one of the reference models for further understanding the developmental cognitive disability associated with DS and may also be used for developing novel therapeutic interventions for this clinical manifestation of the disorder.

[1]  K. Yamakawa,et al.  Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. , 2010, Cerebral cortex.

[2]  Y. Hérault,et al.  A new mouse model for the trisomy of the Abcg1–U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome , 2009, Human molecular genetics.

[3]  George Q. Daley,et al.  Down syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1 , 2009, Nature.

[4]  Paul Antoine Salin,et al.  DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. , 2009, Human molecular genetics.

[5]  Elizabeth M.C. Fisher,et al.  Down syndrome—recent progress and future prospects , 2009, Human molecular genetics.

[6]  J. Macdonald,et al.  Ca2+‐dependent induction of TRPM2 currents in hippocampal neurons , 2009, The Journal of physiology.

[7]  Alberto C. S. Costa,et al.  Acute Injections of the NMDA Receptor Antagonist Memantine Rescue Performance Deficits of the Ts65Dn Mouse Model of Down Syndrome on a Fear Conditioning Test , 2008, Neuropsychopharmacology.

[8]  Michael C. Ostrowski,et al.  Trisomy represses ApcMin-mediated tumours in mouse models of Down’s syndrome , 2008, Nature.

[9]  V. Nouailhetas,et al.  Oxidative stress induced by intense and exhaustive exercise impairs murine cognitive function. , 2007, Journal of neurophysiology.

[10]  N. Nowak,et al.  Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. , 2007, Human molecular genetics.

[11]  P. Wong,et al.  BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice 2 , 2006, Journal of neurochemistry.

[12]  E. Goellner,et al.  Down syndrome with congenital hydrocephalus: case report. , 2006, Arquivos de neuro-psiquiatria.

[13]  Ahmad Salehi,et al.  Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration , 2006, Neuron.

[14]  R. Reeves.  Down syndrome mouse models are looking up. , 2006, Trends in molecular medicine.

[15]  Hey-kyeong Jeong,et al.  DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects , 2006, Neurobiology of Disease.

[16]  Xin Gao,et al.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21 , 2006, Nature.

[17]  Tanja Popovic,et al.  Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001. , 2006, MMWR. Morbidity and mortality weekly report.

[18]  Dean Nizetic,et al.  An Aneuploid Mouse Strain Carrying Human Chromosome 21 with Down Syndrome Phenotypes , 2005, Science.

[19]  J. Roder,et al.  Effects of the rd1 Mutation and Host Strain on Hippocampal Learning in Mice , 2005, Behavior genetics.

[20]  Alberto C. S. Costa,et al.  Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome , 2005, Neuroscience Letters.

[21]  A. Bradley,et al.  Neuronal differentiation of NTE-deficient embryonic stem cells. , 2005, Biochemical and biophysical research communications.

[22]  D. Patterson,et al.  History of genetic disease: Down syndrome and genetics — a case of linked histories , 2005, Nature Reviews Genetics.

[23]  C. Epstein,et al.  Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. , 2005, Mammalian genome : official journal of the International Mammalian Genome Society.

[24]  C. Epstein,et al.  Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(1716)65Dn and mouseChromosome 12 , 2005, Mammalian Genome.

[25]  Stylianos E. Antonarakis,et al.  Chromosome 21 and Down syndrome: from genomics to pathophysiology , 2004, Nature Reviews Genetics.

[26]  R. Malenka,et al.  Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome , 2004, The Journal of Neuroscience.

[27]  D. Borchelt,et al.  APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1 , 2004, Neurobiology of Aging.

[28]  J. Rogers,et al.  Mutagenic Insertion and Chromosome Engineering Resource (MICER) , 2004, Nature Genetics.

[29]  S. South,et al.  Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. , 2004, Genome research.

[30]  J. Roder,et al.  Survey of embryonic stem cell line source strains in the water maze reveals superior reversal learning of 129S6/SvEvTac mice , 2003, Behavioural Brain Research.

[31]  D. G. Rooij,et al.  Male pachytene pairing in single and double translocation heterozygotes and spermatogenic impairment in the mouse , 2004, Chromosoma.

[32]  C. Epstein,et al.  App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome , 2003, The Journal of Neuroscience.

[33]  L. Nadel,et al.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. , 2003, Child development.

[34]  R. Radcliffe,et al.  Contextual and cued fear conditioning in C57BL/6J and DBA/2J mice: context discrimination and the effects of retention interval. , 2002, Behavioral neuroscience.

[35]  J. Macdonald,et al.  Abnormal Spine Morphology and Enhanced LTP in LIMK-1 Knockout Mice , 2002, Neuron.

[36]  A. Sun,et al.  Comparative Analysis of an Improved Thioflavin-S Stain, Gallyas Silver Stain, and Immunohistochemistry for Neurofibrillary Tangle Demonstration on the Same Sections , 2002, Journal of Histochemistry and Cytochemistry.

[37]  T. Pawson,et al.  The Receptor Tyrosine Kinase EphB2 Regulates NMDA-Dependent Synaptic Function , 2001, Neuron.

[38]  K. Gardiner,et al.  Evolutionary breakpoints on human chromosome 21. , 2001, Genomics.

[39]  K. Gardiner,et al.  Ts65Dn – localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome , 2001, Cytogenetic and Genome Research.

[40]  Ahmad Salehi,et al.  Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Richard Paylor,et al.  The use of behavioral test batteries: Effects of training history , 2001, Physiology & Behavior.

[42]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[43]  S. Antonarakis,et al.  Chromosome 21: from sequence to applications. , 2001, Current opinion in genetics & development.

[44]  M. Oshimura,et al.  Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. , 2001, Human molecular genetics.

[45]  C. Epstein,et al.  Genetic Dissection of Region Associated with Behavioral Abnormalities in Mouse Models for Down Syndrome , 2000, Pediatric Research.

[46]  S. J. Martin,et al.  Synaptic plasticity and memory: an evaluation of the hypothesis. , 2000, Annual review of neuroscience.

[47]  R S Chapman,et al.  Behavioral phenotype of individuals with Down syndrome. , 2000, Mental retardation and developmental disabilities research reviews.

[48]  R. Nicoll,et al.  Long-term potentiation--a decade of progress? , 1999, Science.

[49]  Lynn Nadel,et al.  Down syndrome in cognitive neuroscience perspective , 1999 .

[50]  A. Bradley,et al.  A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. , 1999, Nucleic acids research.

[51]  A. Bradley,et al.  Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. , 1998, Genetics.

[52]  C. Torfs,et al.  Anomalies in Down syndrome individuals in a large population-based registry. , 1998, American journal of medical genetics.

[53]  A. Bradley,et al.  Thirteen years of manipulating the mouse genome: a personal history. , 1998, The International journal of developmental biology.

[54]  S. O’Gorman,et al.  Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Rapoport,et al.  Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome , 1997, Neuropharmacology.

[56]  J. Roder,et al.  Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP , 1997, The Journal of Neuroscience.

[57]  R. D'Hooge,et al.  Mildly impaired water maze performance in maleFmr1 knockout mice , 1997, Neuroscience.

[58]  J. Roder,et al.  Enhanced LTP in Mice Deficient in the AMPA Receptor GluR2 , 1996, Neuron.

[59]  M. Pulsifer,et al.  The neuropsychology of mental retardation , 1996, Journal of the International Neuropsychological Society.

[60]  M. Bear,et al.  Long-term depression in hippocampus. , 1996, Annual review of neuroscience.

[61]  A. Bradley,et al.  Chromosome engineering in mice , 1995, Nature.

[62]  M. Dierssen,et al.  A behavioral assessment of Ts65Dn mice: a putative Down syndrome model , 1995, Neuroscience Letters.

[63]  R. Bronson,et al.  A mouse model for Down syndrome exhibits learning and behaviour deficits , 1995, Nature Genetics.

[64]  M. Cioni,et al.  Strength deficit of knee extensor muscles of individuals with Down syndrome from childhood to adolescence. , 1994, American journal of mental retardation : AJMR.

[65]  John O'Keefe,et al.  Hippocampus, theta, and spatial memory , 1993, Current Opinion in Neurobiology.

[66]  L. Nadel,et al.  Down Syndrome in Neurobiological Perspective: An Emphasis on Spatial Cognition , 1993 .

[67]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[68]  P. J. Barrett,et al.  Isokinetic arm and leg strength of adults with Down syndrome: a comparative study. , 1992, Archives of physical medicine and rehabilitation.

[69]  T. Doetschman,et al.  Gene targeting in embryonic stem cells. , 1991, Biotechnology.

[70]  J. Haxby.  Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-demented old adults. , 2008, Journal of mental deficiency research.

[71]  D. Mann,et al.  The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.

[72]  A. Bradley.  Production and analysis of chimeric mice , 1987 .

[73]  T. Teyler.  Long-term potentiation and memory. , 1987, International journal of neurology.

[74]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[75]  U. Mittwoch,et al.  A reciprocal autosomal translocation which causes male sterility in the mouse also impairs oogenesis. , 1985, Journal of reproduction and fertility.

[76]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.

[77]  E. Hook,et al.  Chromosomal abnormality rates at amniocentesis and in live-born infants. , 1983, JAMA.

[78]  P. Vaccaro,et al.  Measurements of neuromuscular tone and strength in Down's syndrome children. , 2008, Journal of mental deficiency research.

[79]  J. Kučera.  [Epidemiology of Down's syndrome (trisomy 21)]. , 1980, Ceskoslovenska pediatrie.

[80]  C. Zadikoff.  Down's syndrome with hydrocephalus treated by compressive head binding. , 1977, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[81]  J. Chusid,et al.  Hydrocephalus in Down's syndrome. , 1976, Child's brain.

[82]  M. Weyland,et al.  [Apropos of a case of combined mongolism and hydrocephalus. Discussion of the etiological factor]. , 1961, Mises au point de l'accoucheur et du pediatre.